A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined with Alemtuzumab as Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) patients requiring initial therapy are often older and frailer and unsuitable candidates for standard chemoimmunotherapy regimens. Shorter duration combination monoclonal antibody (mAb) therapy using alemtuzumab and rituximab has been sho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Zent, Clive S., Wang, Xin Victoria, Ketterling, Rhett P., Hanson, Curtis A., Libby, Edward N., Barrientos, Jacqueline C., Call, Timothy G., Chang, Julie E., Liu, Jane J., Calvo, Alejandro R., Lazarus, Hillard M., Rowe, Jacob M., Luger, Selina M., Litzow, Mark R., Tallman, Martin S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4806550/
https://ncbi.nlm.nih.gov/pubmed/26662208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados